[1-[8-(2,3-dichlorophenyl)sulfanylimidazo[1,2-c]pyrimidin-5-yl]-4-phenylpiperidin-4-yl]methanamine
C24H23Cl2N5S — CID 139427529
Data last refreshed: (MolForge compound catalog, from PubChem)
About [1-[8-(2,3-dichlorophenyl)sulfanylimidazo[1,2-c]pyrimidin-5-yl]-4-phenylpiperidin-4-yl]methanamine
[1-[8-(2,3-dichlorophenyl)sulfanylimidazo[1,2-c]pyrimidin-5-yl]-4-phenylpiperidin-4-yl]methanamine (PubChem CID 139427529) has the molecular formula C24H23Cl2N5S and a molecular weight of 484.46 g/mol. Its IUPAC name is [1-[8-(2,3-dichlorophenyl)sulfanylimidazo[1,2-c]pyrimidin-5-yl]-4-phenylpiperidin-4-yl]methanamine.
Molecular Properties
| Compound Name | [1-[8-(2,3-dichlorophenyl)sulfanylimidazo[1,2-c]pyrimidin-5-yl]-4-phenylpiperidin-4-yl]methanamine |
|---|---|
| PubChem CID | 139427529 |
| Molecular Formula | C24H23Cl2N5S |
| Molecular Weight | 484.46 g/mol |
| Exact Mass | 483.11 |
| IUPAC Name | [1-[8-(2,3-dichlorophenyl)sulfanylimidazo[1,2-c]pyrimidin-5-yl]-4-phenylpiperidin-4-yl]methanamine |
| SMILES | NCC1(c2ccccc2)CCN(c2ncc(Sc3cccc(Cl)c3Cl)c3nccn23)CC1 |
| InChI | InChI=1S/C24H23Cl2N5S/c25-18-7-4-8-19(21(18)26)32-20-15-29-23(31-14-11-28-22(20)31)30-12-9-24(16-27,10-13-30)17-5-2-1-3-6-17/h1-8,11,14-15H,9-10,12-13,16,27H2 |
| InChIKey | CSFYBPIEFKDUEV-UHFFFAOYSA-N |
| XLogP | 5.68 |
| TPSA | 59.45 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 484.46 |
| LogP ≤ 5 | 5.68 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139427529 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.